Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions

NCT02087293 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT02087293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02087293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions
Lead sponsor
Brigham and Women's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2013
Completion date
August 31, 2016
Enrollment
38,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, diabetes, hypertension, insomnia